{"id":342586,"date":"2026-11-09T11:32:32","date_gmt":"2026-11-09T06:02:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=342586"},"modified":"2026-11-09T11:32:32","modified_gmt":"2026-11-09T06:02:32","slug":"gland-pharma-share-price-52-week-high-9-november-2026-q2-fy27-profit-up-58-percent-cdmo-new-ceo-deepak-sapra","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gland-pharma-share-price-52-week-high-9-november-2026-q2-fy27-profit-up-58-percent-cdmo-new-ceo-deepak-sapra\/","title":{"rendered":"Gland Pharma Share Price Jumps to a 52-Week High Despite the Market Sell-Off: Q2 FY27 Profit, CDMO Growth and What to Check"},"content":{"rendered":"

Gland Pharma jumped about 7% to a 52-week high on 9 Nov 2026 (Mint). Q2 FY27 PAT Rs 290.8 crore, up 58%; revenue Rs 1,833.6 crore, up 23%; EBITDA margin 26%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Gland Pharma share price jumped about 7% to a 52-week high on 9 November 2026, according to Mint, after Q2 FY27 profit rose 58% to Rs 290.8 crore and revenue grew 23% to Rs 1,833.6 crore. The rally came despite a weak market, though valuation, a sequential profit dip and a CEO change are worth checking.<\/p>\n<\/p><\/div>\n

The Gland Pharma share price<\/strong> jumped about 7% to a 52-week high<\/strong> on 9 November 2026 after the company reported a 58% rise in Q2 FY27 profit. This article covers what the results show, what drove the quarter, how the valuation looks after the rally and what to check before reacting. Figures are attributed and time-stamped, and I have no live quote, so verify the current price on NSE or BSE.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n